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Arterial calciﬁcation is a well-known risk factor for coronary artery disease (CAD) and myocardial
infarction (MI). We performed a genome-wide association study on coronary artery calciﬁcation and
aortic calciﬁcation as intermediate traits for CAD/MI. We tested w2.5 million SNPs for association with
coronary artery calciﬁcation and aortic calciﬁcation in 2620 male individuals of the NELSON trial, who
underwent chest CT scans. All participants were current or former heavy smokers. No SNPs were asso-
ciated with aortic calciﬁcation on a genome-wide scale. The 9p21 locus was signiﬁcantly associated with
coronary artery calciﬁcation (rs1537370, P ¼ 2.3  1011). Since this locus corresponds to the strongest
SNP association for CAD/MI, we tested 24 published and validated CAD/MI risk SNPs for association with
arterial calciﬁcation. Besides the CAD/MI SNP at 9p21 (rs4977574, P ¼ 3.1  1010), two additional loci at
ADAMTS7 (rs3825807, P ¼ 6.5  106) and at PHACTR1 (rs12526453, P ¼ 1.0  103) show a nominally
signiﬁcant association with coronary artery calciﬁcation with MI/CAD risk alleles increasing the degree of
arterial calciﬁcation. The 9p21 locus was also nominally associated with aortic calciﬁcation (P ¼ 3.2  10
4). These ﬁndings indicate that these CAD and MI risk loci are likely involved in arterial calciﬁcation.
 2013 Elsevier Ireland Ltd.Open access under the Elsevier OA license.er Utrecht, Departments of
10, P.O. Box 85500, 3508 GA
: þ31 88 75 55410.
de Bakker).
er the Elsevier OA license.1. Introduction
Cardiovascular diseases are the leading cause of morbidity and
mortality in the world. Calciﬁcation of coronary arteries and the
Table 1
NELSON/COPACETIC study information.
Number of samples after QC 2620
Groningena/Utrechtb 1484/1136
Median aorta score 498 (IQR 90-1842) mm3
Median Agatston score 127 (IQR 6-736) HU
Average pack years 40.4 (sd 17.1)
Average age 59.9 (sd 5.5)
Abbreviations: IQR: interquartile range, HU: Hounsﬁeld Units, sd: standard
deviation.
a Samples collected at the University Medical Center Groningen.
b Samples collected at the University Medical Center Utrecht.
J. van Setten et al. / Atherosclerosis 228 (2013) 400e405 401aorta is a major risk factor for coronary artery disease (CAD) and
myocardial infarction (MI), independent of well-known risk factors,
including cholesterol levels, body mass index, smoking behavior,
age, gender, and family history [1,2]. Recent genome-wide associ-
ation studies have identiﬁed 25 genomic regions reproducibly
associated with CAD/MI risk [3]. Of these 25 loci, eight are clearly
linked to genes that modulate lipid levels in the circulation,
including LDL-cholesterol and triglycerides [4]. The functional
basis of the remaining 17 loci associated with CAD/MI is poorly
understood, suggesting a role for mechanisms other than lipid
metabolism.
In this study, we used quantitative computed tomography (CT)
analysis to measure calciﬁcation levels in coronary arteries and
aorta in a cohort of heavy smokers. Heritability estimates of coro-
nary artery and aortic calciﬁcation are approximately 50% [5,6],
making them suitable intermediate traits. We performed a
genome-wide study of these continuous traits, testing 2.5 million
common SNPs across the genome. We demonstrate that three
previously found CAD/MI risk loci are associated with arterial
calciﬁcation.
2. Methods
2.1. Cohort description
The Dutch and Belgian Lung Cancer Screening Trial (NELSON
trial) [7,8]wasdesigned to study the early detectionof lung cancer in
an at-risk population. In total, 15,523 participants were enrolled at
two different locations: the University Medical Center Groningen
and the University Medical Center Utrecht. The study was approved
by the Ministry of Health of the Netherlands and written informed
consent was obtained from all participants. Screening trial partici-
pants were current or former (<10 year) heavy smokers (predomi-
nantlymales) between50and75yearsof agewitha smokinghistory
of at least 16 cigarettes/day for 25 years or at least 11 cigarettes/day
for 30 years (i.e.>16.5 pack years), with an average smoking history
of 40 pack years. Exclusion criteriawere a self-reportedmoderate or
bad healthwith inability to climb 2ﬂights of stairs, a recent chest CT,
current or past cancer, and a body weight 140 kg.
2.2. CT-based imaging
Low-dose, non-ECG synchronized, non-contrast enhanced base-
line chest CTs were available for all participants. CTs were acquired
on a 16 detector-row scanner (Mx8000 IDT, Somatom Sensation 16,
or Brilliance 16P, Philips Medical Systems, Cleveland, OH, USA) in
spiral mode with 16  0.75 mm collimation. Axial images of 1.0 mm
thickness at 0.7 mm increment were reconstructed with a moder-
ately soft kernel (Philips “B”). The peak voltage was 120e140 kVp
depending on patient weight, with a tube current of 30 mAs. A
detailed description of the inclusion criteria and the scanning pro-
tocol is provided by van Klaveren et al. [8] To perform calcium
scoring with the usual section thickness, CTs were subsampled to
3.1 mm thick sections with a total increment of 1.4 mm [9].
We developed computer-aided systems for automatic detection
and quantiﬁcation of aortic and coronary calciﬁcations [10,11]. A
threshold of 130 Hounsﬁeld units was used to identify potential
calciﬁcations, which were extracted by three-dimensional con-
nected component labeling. Coronary calciﬁcations were detected
using a system based on a previously described algorithm [10].
First, a probabilistic coronary calcium map was designed, which
provided an a priori probability for spatial appearance of coronary
calciﬁcations in a chest CT scan. This was followed by a supervised
pattern recognition system which detected calciﬁcations based on
spatial and texture information. Aortic calciﬁcations were detectedusing a multi-atlas-based segmentation of the aorta, followed by a
supervised pattern recognition system which detected aortic cal-
ciﬁcations based on the spatial, size and texture features [11]. After
manual inspection by up to four experienced observers, calciﬁca-
tions in the aorta were quantiﬁed in terms of total volume calcium
score (mm3), while coronary artery calciﬁcations were measured in
terms of the Agatston score [12].
2.3. Genotyping and quality control
As part of the COPACETIC study, genome-wide SNP genotype
datawas collected in 3082 randomly sampled participants from the
NELSON trial (Table 1). DNA samples were obtained from
blood using a high salt method [13], and hybridized on Illumina
Quad610 BeadChip containing 620,901 markers providing good
coverage of common SNP variation. Genotypes were called with the
GenomeStudio software by Illumina. Quality control was per-
formed on sample and SNP level using PLINK [14].
A ﬂowchart of the sample selection and quality control is shown
in Figure S1. We removed 264 samples with a rate of missing ge-
notypes >2%. We selected high quality SNPs by applying the
following ﬁlters: missing rate <1%, Hardy-Weinberg P > 0.001,
minor allele frequency >10%, and LD-pruning (leaving no pairs
with R2 > 0.05), resulting in 64,902 SNPs. Using these SNPs, we
removed 56 samples with heterozygosity >2 standard deviations
from the mean of all samples, and 49 samples of non-European
ancestry, on the basis of principal component analysis using ten
HapMap 3 populations (CEU, YRI, JPT þ CHB, ASW, CHD, GIH, LWK,
MEX, MKK, and TSI) as reference. We also removed 39 related
samples (proportion of IBD>0.2), keeping only the samplewith the
lowest missingness. Since we only had data available on 14 females,
we excluded those samples from all analyses.
Before genome-wide imputation, we removed SNPs if the
missing rate was >2%, minor allele frequency <0.05, HardyeWein-
berg P< 0.001,missing genotyping rate greater than theminor allele
frequency, or allele frequency difference to HapMap-CEU > j0.15j.
After these quality control steps, we repeated principal
component analysis without HapMap samples, based on the same
high quality SNPs as described above, to estimate the ﬁrst 20
principal components. We tested each of the principal components
for association with coronary artery and aortic calciﬁcation (using
linear regression with age and smoking history as covariates), and
detected that 13 of 20 components were nominally signiﬁcant
(P < 0.05). We included these 13 principal components as cova-
riates in all association analyses. We also performed genome-wide
association for each individual principal component (as a quanti-
tative trait), but we found no evidence for global inﬂation.
2.4. Imputation
Imputation of untyped SNPs was performed in batches of 300
randomly drawn individuals. Using Beagle 3.0.4 [15], we performed
imputationwith 120 phased haplotypes from CEU HapMap phase 2
J. van Setten et al. / Atherosclerosis 228 (2013) 400e405402data (UCSC hg18/NCBI 36) [16] encompassing 2,543,807 SNPs. Of
the 25 SNPs previously associated with CAD/MI, 23 were success-
fully imputed. Two SNPs (rs17465637 and rs3798220) could not be
imputed because they were absent from HapMap-CEU. One
(rs17465637) had a good proxy (rs17011681, R2 ¼ 1 in 1000 Ge-
nomes pilot 1) that could be included in the analysis. Another SNP
(rs3798220) had no good proxies and was therefore excluded from
the analysis.
2.5. Association analysis
We performed a genome-wide association study on Agatston
scores and calcium volume as measures for coronary artery calci-
ﬁcation and aortic calciﬁcation, respectively, in 2620 individuals
from the NELSON trial. Both phenotypes were loge transformed
(ln(score þ1)) to obtain a normally distributed range of calcium
scores (Figure S2). We used a linear regression model with age,
smoking history (pack years), and principal components (to correct
for population structure) [17] as covariates. Smoking history and
age were independently correlated with calcium scores (P < 0.01
for both coronary artery and aortic calciﬁcation).
Genomic inﬂation (lGC) [18] was low before and after imputa-
tion (l  1.024 for coronary artery and aortic calciﬁcation,
Figure S3), suggesting the inﬂuence of population structure and
other technical biases was minimal. Since low frequency SNPs and
SNPs with low imputation-quality scores showed little genomic
inﬂation (l ¼ 0.98 for minor allele frequency < 0.05, l ¼ 1.05 for
imputation-quality <0.25), we decided not to remove these
SNPs. Genome-wide signiﬁcance for novel associations is set at
P < 5  108.
2.6. CAD/MI lookup
Twenty-four previously described risk SNPs for CAD and MI [3]
were tested for associations with aortic and coronary artery calci-
ﬁcation.We set statistical signiﬁcance at P< 0.05/24¼ 0.0021 using
Bonferroni correction, reﬂecting an elevated prior probability of
being associated on the basis of evidence from GWAS of CAD/MI.
Using this threshold, we have sufﬁcient power (>80%) to detect
associations with SNPs that account for at least 0.6% of genetic
variance. We calculated a genetic risk score (GRS) for each sample,
deﬁned by the total number of risk alleles they carry weighted by
the ln(OR) reported by the CARDIoGRAM study. We tested this GRS
for association with aortic and coronary artery calciﬁcation using
linear regression with age, smoking history and principal compo-
nents as covariates.
3. Results
3.1. Genome-wide association analysis
After testing 2.5 million SNPs for association with coronary ar-
tery and aortic calciﬁcation levels measured in 2620 NELSON par-
ticipants, we found no genome-wide signiﬁcant associations for
aortic calciﬁcation but observed one region signiﬁcantly associated
with coronary artery calciﬁcation (Table S1 and Figure S4). This
region is located on chromosome 9p21 near CDKN2A/CDKN2B with
37 SNPs that exceed genome-wide signiﬁcance (P < 5  108). SNP
rs1537370 is the most signiﬁcant SNP with the T allele increasing
the Agatston score (P ¼ 2.3  1011). This SNP is highly correlated
(pairwise r2 > 0.9 in European populations) to the SNP rs4977574,
reported by the CARDIoGRAM study [3] as being associated with
CAD/MI. Conditional analysis on these two SNPs shows that they
are statistically indistinguishable, consistent with the high degree
of LD between the two SNPs.3.2. CAD/MI look-up
Since the 9p21 locus has been previously associated with CAD/
MI, we decided to test all known CAD/MI risk SNPs for association
with aortic and coronary artery calciﬁcation. Results for 24 SNPs are
shown in Table 2. Three SNPs are signiﬁcantly associated with
coronary artery calciﬁcation (Figure S5): rs3825807 (ADAMTS7,
P ¼ 6.5  106), rs12526453 (PHACTR1, P ¼ 1.0  103) and
rs4977574 (CDKN2A/CDKN2B, P ¼ 3.1  1010). SNP rs4977574 at
9p21 is also signiﬁcantly associated with calciﬁcation in the aorta
(P ¼ 3.2  104). All these associations were consistent with the
expected direction of effect: CAD/MI risk alleles increased calciﬁ-
cation levels. After adjusting for known CAD/MI loci, the resulting
distribution of SNP associations across the genome is consistent
with chance expectation (Figure S6).
Approximately ten percent of our study population (n ¼ 473)
had no detectable calciﬁcation in their coronary arteries (Figure S2).
We removed all individuals with zero Agatston scores, repeated the
association analysis and found that qualitatively all results remain
unchanged. At 9p21, PHACTR1, and ADAMTS7, all SNPs are still
signiﬁcantly associated with coronary artery calciﬁcation
(P ¼ 5.0  105 for rs4977574 at 9p21, P ¼ 1.4  104 for rs3825807
at ADAMTS7, P ¼ 0.003 for rs12526453 at PHACTR1). When we split
our population in one group with zero Agatston scores (as “cases”),
and another group with non-zero scores (as “controls”), two out of
three SNPs are associated at the nominal level (P ¼ 1.2  106 for
rs4977574 at 9p21, P ¼ 0.002 for rs3825807 at ADAMTS7, P ¼ 0.12
for rs12526453 at PHACTR1).
3.3. Genetic risk score
We tested the collective impact of 24 CAD/MI SNPs on the de-
gree of calciﬁcation in the coronary arteries and aorta. For each
sample we derived a GRS by counting in each individual the
number of risk alleles, multiplied by the ln(OR) as reported by the
CARDIoGRAM study. Fig. 1 shows the relation between the GRS
(divided in eight equal groups) and the observed degree of
calciﬁcation.
Using linear regression adjusting for age, smoking history, and
principal components, we observed a statistically signiﬁcant asso-
ciation between the GRS and coronary artery calciﬁcation
(P ¼ 1.1  1014). The GRS explains 2.4% of the variance of the
Agatston score in our cohort. There is a signiﬁcant difference in
Agatston scores between the lower and upper GRS bins (Fig. 1a),
with on average almost ten times greater Agatston scores in in-
dividuals in the highest GRS bin compared to individuals in the
lowest GRS bin. Although the relation between the GRS and aortic
calciﬁcation was nominally signiﬁcant (P ¼ 9.0  103), the trend
across GRS bins is much less pronounced, with only 0.2% variance
explained of aortic calciﬁcation.
4. Discussion
In a large cohort of heavy smokers we quantiﬁed calciﬁcations in
the aorta and coronary arteries on chest CT scans using automated
CT imaging analysis and tested 2.5 million common SNPs for as-
sociation with these two continuous traits. We found a signiﬁcant
association signal at the CDKN2A/CDKN2B locus as well as nomi-
nally signiﬁcant signals at ADAMTS7 and PHACTR1. Overall, this
provides a potential biological mechanism that links vascular
calciﬁcation to CAD and MI.
The 9p21 locus is signiﬁcantly associated with coronary artery
calciﬁcation, consistent with previously published results [19]. To
our knowledge, we are the ﬁrst to describe a signiﬁcant association
between 9p21 and aortic calciﬁcation. In addition, this locus has
Table 2
Association results for 24 CAD/MI risk SNPs.
SNP info CARDIoGRAM Agatston score Aortic calciﬁcation
rsID Locus Gene Coded
allele
Non-coded
allele
Frequency Odds ratio Beta SE P-value Beta SE P-value
rs599839 1p13.3 SORT1 A G 0.78 1.11 0.072 0.093 0.437 0.096 0.082 0.241
rs17114036 1p32.2 PPAP2B A G 0.91 1.17 0.175 0.141 0.216 0.196 0.125 0.117
rs11206510 1p32.3 PCSK9 T C 0.82 1.08 0.003 0.103 0.975 0.053 0.091 0.563
rs17011681 1q41 MIA3 C G 0.74 1.14 0.296 0.118 0.012 0.114 0.104 0.277
rs6725887 2q33.1 WDR12 C T 0.15 1.14 0.061 0.115 0.594 0.009 0.102 0.931
rs2306374 3q22.3 MRAS C T 0.18 1.12 0.025 0.105 0.817 0.039 0.093 0.675
rs17609940 6p21.31 ANKS1A G C 0.75 1.07 0.022 0.096 0.819 0.056 0.085 0.508
rs12190287 6p23.2 TCF21 C G 0.62 1.08 0.108 0.103 0.292 0.015 0.091 0.875
rs12526453 6p24.1 PHACTR1 C G 0.67 1.10 0.287 0.084 0.001 0.032 0.075 0.664
rs11556924 7q32.2 ZC3HC1 C T 0.62 1.09 0.112 0.093 0.229 0.009 0.083 0.914
rs4977574 9p21.3 CDKN2A/CDKN2B G A 0.46 1.29 0.497 0.079 3.14E-10 0.253 0.070 3.21E-04
rs579459 9q34.2 ABO C T 0.21 1.10 0.100 0.096 0.299 0.121 0.085 0.155
rs1746048 10q11.21 CXCL12 C T 0.87 1.09 0.161 0.117 0.168 0.064 0.103 0.535
rs12413409 10q24.32 CYP17A1/CNNM2/NT5C2 G A 0.89 1.12 0.034 0.147 0.813 0.054 0.129 0.675
rs964184 11q23.3 ZNF259/APOA5-A4-C3-A1 G C 0.13 1.13 0.267 0.118 0.024 0.007 0.105 0.943
rs3184504 12q24.12 SH2B3 T C 0.44 1.07 0.114 0.080 0.154 0.012 0.071 0.870
rs4773144 13q34 COL4A1/COL4A2 G A 0.44 1.07 0.160 0.169 0.341 0.062 0.149 0.677
rs2895811 14q32.2 HHIPL1 C T 0.43 1.07 0.029 0.079 0.716 0.110 0.070 0.117
rs3825807 15q25.1 ADAMTS7 A G 0.57 1.08 0.363 0.080 6.50E-06 0.070 0.071 0.327
rs12936587 17p11.2 RASD1/SMCR3/PEMT G A 0.56 1.07 0.163 0.083 0.050 0.111 0.074 0.130
rs216172 17p13.3 SMG6/SRR C G 0.37 1.07 0.099 0.081 0.223 0.079 0.072 0.272
rs46522 17q21.32 UBE2Z/GIP/ATP5G1/SNF8 T C 0.53 1.06 0.024 0.078 0.757 0.006 0.069 0.932
rs1122608 19p13.2 LDLR G T 0.77 1.14 0.031 0.091 0.737 0.010 0.081 0.901
rs9982601 21q22.11 MRPS6 T C 0.15 1.18 0.143 0.114 0.210 0.121 0.101 0.233
Twenty-four CAD/MI risk SNPs were tested for association with coronary artery calciﬁcation and aortic calciﬁcation. Odds ratio from CARDIoGRAM taken from Ref. [3]. The
frequency, odds ratio, effect estimates (beta) and standard error (SE) are given for the coded allele.
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abdominal aortic aneurysms, intracranial aneurysms, stroke, pe-
ripheral artery disease, type 2 diabetes, and several cancers, rein-
forcing the idea that this locus has pleiotropic effects [20]. The locus
contains a large non-coding RNA gene named ANRIL. Two cyclin-
dependent kinases inhibitors, CDKN2A and CDKN2B are located
about 100 kb away from the top signal at rs4977574. Expression
of these three genes has been associated with a number of
atherosclerosis-related phenotypes [21]. It has been shown that
mice lacking an orthologous 70-kb region have a reducedFig. 1. Correlation between genetic risk score and arterial calciﬁcation. Genetic risk scores
weighted by their reported effect sizes. Scores are correlated with coronary artery calciﬁca
terms of total volume calcium score (b). Low levels of coronary artery calciﬁcation are evide
aortic calciﬁcation, but still statistically signiﬁcant.expression of CDKN2A and CDKN2B [22]. Deletion of this genomic
region in humanmutant aortic smoothmuscle cells in culture leads
to a doubling of proliferative capacity, which is a cellular phenotype
relevant to atherosclerosis [22]. In addition, Motterle et al. showed
that the CAD risk allele of SNP rs1333049 (pairwise R2 ¼ 0.97 with
rs4977574 in 1000 Genomes pilot 1) was associated with a
decreased expression of CDKN2A, CDKN2B, and ANRIL, and with an
increased proliferation of vascular smooth muscle cells [23]. This
locus should therefore be investigated for its role in calciﬁcations in
the vascular wall and how it confers risk to CAD/MI.are based on the number of risk alleles for 24 previously described CAD/MI risk loci,
tion measured in terms of the Agatston score (a) and aortic calciﬁcation quantiﬁed in
nt in individuals with a lower genetic risk score. The correlation is less pronounced for
J. van Setten et al. / Atherosclerosis 228 (2013) 400e405404Our second signiﬁcant SNP rs3825807 encodes a missense
change (Pro214Ser) in ADAMTS7, which is a member of the ADAMTS
(a disintegrin and metalloproteinase with thrombospondin motifs)
family. This amino acid substitution is predicted to be “benign”
according to PolyPhen-2 [24], leaving it unresolved as to whether
this SNP is the causal variant affecting calciﬁcation. ADAMTS7 plays
a role in vascular smooth muscle cell migration and intimal thick-
ening after vascular injury, and it has been shown that this process
is at least partially mediated by ADAMTS7-dependent degradation
of the extracellular matrix protein COMP (cartilage oligomeric
matric protein) [25]. Two hundred kb downstream of ADAMTS7, a
SNP rs1051730 is associated with smoking [26], and is in LD with
our index SNP rs3825807 (pairwise R2 ¼ 0.43 in 1000 Genomes
pilot 1). Adjusting for rs1051730, we still observed residual asso-
ciation at rs3825807 (P ¼ 0.0024), suggesting that our signal is
independent from the smoking risk locus.
The third SNP signiﬁcantly associated with coronary artery
calciﬁcation is located in an intron of PHACTR1 (phosphatase and
actin regulator 1), the only gene within 200 kb of this SNP. The
PHACTR1 gene product is thought to regulate protein phosphatase 1
(PP1), an enzyme that dephosphorylates serine and threonine
residues on a range of proteins [27]. Furthermore, Jarray et al.
suggest that this gene is important in tube formation and endo-
thelial cell functioning [28].
Interestingly, Reilly et al. argued that these three loci are all
associated with angiographic CAD, but not with MI in angiographic
CAD positive patients, leading them to suggest that these genes
play only an indirect role in MI [29]. Possibly these three genes
might exert their effects on arterial calciﬁcation, thus contributing
only indirectly to MI.
Our results are consistent with recent results presented by
O’Donnell and colleagues [19]. They found two loci (CDKN2A/
CDKN2B and PHACTR1) associated with coronary artery calciﬁcation
at genome-wide signiﬁcance, with additional evidence for four CAD/
MI SNPs, including SORT1, MRAS, COL4A1/COL4A2, and ADAMTS7.
Hence, our study provides independent replication evidence for
CDKN2A/CDKN2B, PHACTR1 and ADAMTS7, and observes also
consistent effects in the same direction for the remaining three loci.
We tested for the robustness of our results by removing in-
dividuals with zero Agatston scores, and by dichotomizing the
Agatston score distribution in a group with zero scores and a group
with non-zero scores. These results of these association tests are
consistent with a model where the associated SNPs at 9p21,
PHACTR1 and ADAMTS7 inﬂuence levels of calciﬁcation in all in-
dividuals and where individuals with zero Agatston scores are
particularly enriched for protective alleles that lower calciﬁcation.
When we combine the 24 CAD/MI SNPs into a GRS, we observe
that the prevalence of coronary artery calciﬁcation, and in lesser
extent aortic calciﬁcation, increases with greater GRS. This may be
clinically relevant because low amounts of coronary calciﬁcations
are generally associated with good prognosis and may be used to
reclassify subjects to low cardiovascular risk [30].
Since the NELSON trial was set up to screen for lung cancer in a
heavy smoking population, information on cardiovascular risk
factors such as diabetes and hypertension was not collected. It is
unclear to what extent genes associated with these risk factors
(and with lung cancer) have inﬂuenced the study results, but the
consistency of the associations observed for coronary calciﬁcation
and CAD/MI is certainly compelling and makes it rather unlikely
that the present results are due to confounding. Furthermore, we
are unaware of an etiological link between lung cancer and coro-
nary calciﬁcation. Over the whole NELSON trial, the number of
incident lung cancer cases is very low and unlikely to inﬂuence (or
explain) our results. Nevertheless, a potential link cannot be
excluded, since coronary artery calciﬁcation is strongly correlatedwith all-cause mortality, even if other risk factors are taken into
account [30].
The principal limitation of our study is the sample size and
power to detect novel associations. Although the effect of 9p21
appears to be shared between coronary artery and aortic calciﬁ-
cation, separate mechanisms may still be involved, even if there is
weak correlation between calciﬁcation in the aorta and coronaries
(r2 ¼ 0.13 in our data). Larger studies will be needed to study the
genetic basis of calciﬁcation in different parts of the vasculature.
The exact causal variants that drive the observed associations are as
yet unknown, and future ﬁne-mapping studies should shed light on
their identity and function. Lastly, the present data are not sufﬁ-
cient to demonstrate the order of events related to vascular calci-
ﬁcation, CAD and MI. Future studies are necessary to test the
hypothesis if vascular calciﬁcation leads to atherosclerosis, or if
atherosclerosis ultimately causes calciﬁcation of the vessel wall.
In a study comprising 2620 current and former heavy smoking
males, our results show that at least three genes that have previ-
ously been associated with CAD and MI are possibly involved in
arterial calciﬁcation. These ﬁndings provide a better understanding
of the biological mechanisms behind vascular calciﬁcation and
cardiovascular diseases.
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